19.3 C
New York
Friday, September 24, 2021

A new bioprocessing facility in Westmeath will create 60 jobs

Must read

Antylia Scientific will hire in the areas of process and medical device engineering, manufacturing, logistics and supply chain.

US-headquartered biotech company Antylia Scientific will establish a new bioprocessing facility in Co Westmeath.

Click here to check out the top sci-tech employers hiring right now.

The new state-of-the-art manufacturing centre will create 60 new roles in the areas of process and medical device engineering, manufacturing as well as logistics and supply chain.

Antylia Scientific produces peristaltic and bioprocessing solutions and has a diverse portfolio of life sciences and diagnostic products for the pharma, biopharma, healthcare, and environmental markets. The company owns Masterflex, which produces peristaltic pumps and pump systems.

The new bioprocessing facility will be used to design and manufacture the company’s Masterflex peristaltic technologies, which are used in pharmaceutical and bioprocessing workflows for the development and production of vaccines and therapeutics.

The facility will also include a large warehouse space to store components and the finished products.

This investment could expand access to these critical fluid path products and provide customers with shorter lead times, simplified sourcing and validation and increased supply for these critical fluid path products.

Brian Barnett, president of Masterflex Bioprocessing said: “We are thrilled to open our first facility in Ireland to produce and house Masterflex peristaltic technologies and associated fluid path products. These products are in great demand globally. The addition of this site to our Masterflex Bioprocessing family of global sites providing mission critical products and services will help the overall Biopharma industry.”

Minister for Trade Promotion, Digital and Company Regulation Robert Troy, TD, said the announcement is a strong endorsement for the midlands. “Our highly skilled workforce is just one reason why Ireland is recognised as a global hub for leading biopharmaceutical companies like Antylia Scientific,” he said.

IDA Ireland’s CEO, Martin Shanahan, said: “Antylia Scientific’s significant investment in its Mullingar facility based at the National Science Park demonstrates the company’s commitment to the Midlands region.”

More information about the opportunities to join the Mullingar team are available on Antylia Scientific’s LinkedIn.

- Advertisement -spot_img

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -spot_img

Latest article